皓元医药: 上海皓元医药股份有限公司关于控股股东可转债持有比例变动达到10%的公告

Group 1 - The company issued 8,223,500 convertible bonds with a total value of 82,235,000 RMB, each with a face value of 100 RMB, and a maturity of 6 years [1][2] - The controlling shareholder, Shanghai Anxu Information Technology Co., Ltd., acquired 2,653,870 bonds, representing 32.27% of the total issuance [2] - From July 8 to July 14, 2025, the controlling shareholder reduced its holdings by 925,460 bonds, bringing the total holdings down to 1,728,410 bonds, which is 21.02% of the total issuance [2]